Pediatric Patients with Type 1 Diabetes The efficacy of TOUJEO was evaluated in a 26-week, randomized, open-label, multicenter trial (Study B) in 463 pediatric patients with type 1 diabetes mellitus
This dual-action method not only suppresses appetite but also slows down gastric emptying, which contributes to smaller portion sizes and greater overall satisfaction with meals
Serious AEs were more frequent in the PIONEER 6 than the other PIONEER studies, having occurred in 18.9% to 22.5% of patients in the semaglutide 14 mg and placebo treatment groups, respectively
Dev Cell 2015;32:3142
Step 2: Complete an Online Visit Our licensed provider team will engage with you entirely online to discuss your health, past attempts at weight loss, and what to anticipate moving forward
Conference Reports for NATAP Conference on Retroviruses and Opportunistic Infections Denver, Colorado March 3-6 2024 Back Tweet Low-Dose Semaglutide Cuts Weight, Triglycerides, and Glucose in HIV MASLD Group CROI 2024 (Conference on Retroviruses and Opportunistic Infections), March 3-6, 2024, Denver Mark Mascolini Low-dose once-weekly semaglutide for 24 weeks lowered intrahepatic triglycerides (IHGT) in people with HIV and metabolic dysfunction-associated steatotic liver disease (MASLD) [1]